Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Releases Draft Guidelines On 513(g) Device Classification Requests

This article was originally published in The Gray Sheet

Executive Summary

FDA released two draft guidances April 29 to help firms better understand the agency's 513(g) device classification request program - and when the costly voluntary filings are unnecessary

You may also be interested in...



Regulatory News In Brief

FDA issues final guidances on 513(g) requests for information on device classifications. Panel to meet June 13 on expanded indication for Sapien transcatheter valve. More FDA news.

513(g) Device Classification Requests Drop; FDA Plans Guidance

FDA's device center has seen a big drop-off in 513(g) requests since a new user fee put a hefty price tag on the voluntary product classification queries

Device Classification Request Filings Often Unnecessary, Says FDA Official

Companies should think twice before filing a 513(g) request, given that the formal information queries are now subject to user fees and often could be answered by a simple phone call to FDA, says an agency official

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel